BioHealth News Archive
UMD announces $1.5 billion fundraising campaign that’s halfway complete – The Diamondback
The University of Maryland announced its goal Friday to fundraise $1.5 billion by the end of 2021 for numerous construction projects, scholarship funds and…
Read MoreSeoul to spend massive money in biohealth sector – Korea Biomedical Review
The government said Friday it would spend 7.5 trillion won ($7 billion) to support the biohealth sector by 2022 aggressively. The Ministry of Trade,…
Read More4 States Control 80 Percent of Venture Capital Dollars – MARYLAND ranked 5th
More than half of all venture capital dollars invested in small businesses and startups during the first three months of 2018 went straight into…
Read MoreArmy Doctors Grew a Soldier a New Ear — On Her Forearm – Time
You’ve heard the cliché about wearing your heart on your sleeve. But a group of Army doctors did one better: They grew a new…
Read MoreJohns Hopkins effort to promote economic growth in Baltimore exceeds expectations – Hub
It pays to be a business in Baltimore. That's the message that Johns Hopkins wants proprietors and their patrons to know as part of…
Read MoreMedical device inventor Robert E. Fischell gives University of Maryland School of Medicine $20 million to establish center for biomedical innovation – Baltimore Business Journal
Famous local inventor Robert E. Fischell is gifting $20 million to the University of Maryland School of Medicine in support of biomedical research. The gift…
Read MoreJapan’s Takeda clinches $62 billion Shire deal as pharma M&A rolls on – Reuters
Takeda Pharmaceutical agreed to buy London-listed Shire for 45.3 billion pounds ($62 billion) on Tuesday, the biggest yet in a wave of deals sweeping…
Read MoreTraumatic Brain Injury Research by Emmes Corporation, LDS Hospital, Lovelace Biomedical
The Emmes Corporation today announced that scientists and health professionals from the company, LDS Hospital in Salt Lake City, Utah, Lovelace Biomedical Environmental Research…
Read MoreEmergent BioSolutions Moves Things Around — The Motley Fool
The first-quarter numbers for Emergent BioSolutions (NYSE:EBS) didn't look too great. In fact, they were arguably ugly. {iframe}https://www.fool.com/investing/2018/05/08/emergent-biosolutions-moves-things-around.aspx{/iframe}
Read MoreBeneVir Biopharm Inc. to be acquired by Janssen Biotech Inc. for up to $1.04B – Washington Business Journal
Rockville-based BeneVir Biopharm Inc., a biotech specializing in immunotherapy treatments for cancer, has reached a deal to sell to pharmaceutical goliath Janssen Biotech Inc.,…
Read MoreThe Collective Seattle Is A Clubhouse For Big Kids – Commercial Real Estate
Think of The Collective as a 15K SF clubhouse for big kids. Grownups are welcome, but leave your electronic devices in your pockets, please.…
Read More1.13M Patient Records Breached from January to March 2018 – Protenus
1,129,744 patient records were breached between January and March 2018, according to new data released today in the Protenus Breach Barometer. Published by Protenus,…
Read MoreMechanistic and Human Translational Results for BT-11 in Models of IBD – Landos Biopharma
Landos Biopharma, Inc., an emerging biopharmaceutical company focused on developing improved treatments for autoimmune diseases, announced the publication of findings on the mechanisms of…
Read MoreBioBuzz with UMBC Shady Grove
When: Wednesday, May 16, 2018 from 5:00 PM to 7:00 PM EDT Where: UMBC Shady Grove, 9630 Gudelsky Drive ,Rockville, MD 20850 Join BioBuzz…
Read MoreWhat percentage of investments by provider ventures are actually getting adopted? – MedCity News
Provider venture funds are more active than ever before and their perspectives were a topic of discussion at the newest megaconference on the healthcare…
Read More